Skip to main content
Top

Open Access 09-06-2025 | Gastrointestinal Microbiota

Mechanisms of exercise in preventing cardiovascular diseases: Insights from gut microbiota characteristics in pathological states of cardiovascular diseases

Authors: Xingyu Qian, Yilan Guo, Peng Sun

Published in: Reviews in Endocrine and Metabolic Disorders

Login to get access

Abstract

Cardiovascular diseases (CVD) are major lethal diseases worldwide. Imbalance of gut microbiota (GM) homeostasis affects the development and progression of CVD. Exercise can remodel GM and improve GM disorders in CVD patients. By combing the research progress of GM-mediated exercise intervention for CVD, it was found that 1) Streptococcus, Lactococcus, Enterobacter, Klebsiella, and Turicibacter are pathogenic bacteria in CVD patients; 2) Response to exercise to modulate the microbiota of CVD includes increasing the abundance of beneficial bacteria such as Bifidobacteria, Lactobacillus, Bacteroides, Faecalobacteria, and Roseburia, decreasing the proportion of Streptococcus, Enterobacter, and other pathogenic bacteria, and regulating metabolite-producing bacteria such as Prevotella and Ruminococcus; 3) Exercise can improve the CVD process via GM, by remodeling physiological mechanisms such as vascular function, cardiac function, autonomic function and hemodynamics, and molecular mechanisms such as regulation of DNA methylation, histone modification, non-coding RNAs; 4) Most of the existing studies have focused on aerobic exercise. The specific mechanisms, individualized intervention programs and long-term effects of different types of exercise on GM in CVD patients need to be further explored.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Mechanisms of exercise in preventing cardiovascular diseases: Insights from gut microbiota characteristics in pathological states of cardiovascular diseases
Authors
Xingyu Qian
Yilan Guo
Peng Sun
Publication date
09-06-2025
Publisher
Springer US
Published in
Reviews in Endocrine and Metabolic Disorders
Print ISSN: 1389-9155
Electronic ISSN: 1573-2606
DOI
https://doi.org/10.1007/s11154-025-09971-8

Innovations in AML: insights and practical guidance

Hear directly from acute myeloid leukemia experts in this vodcast series focussing on innovations in molecular testing, emerging therapies, and targeted treatments, and get practical advice for improving the care of your patients with relapsed or refractory disease.

Supported by:
  • Rigel Pharmaceuticals, Inc.
Developed by: Springer Health+ IME
Learn more

ADA 2025

Unlock your free and exclusive access to the latest news from the American Diabetes Association’s 85th Scientific Sessions.

Read more